Literature DB >> 9192172

M3 muscarinic receptor mediates regulation of protein secretion in rabbit lacrimal gland.

M Nakamura1, Y Tada, T Akaishi, K Nakata.   

Abstract

PURPOSE: To identify which muscarinic receptor subtypes mediate protein secretion in isolated rabbit lacrimal glands. To compare protein secretory profiles in vitro with those in rabbit tears.
METHODS: Rabbit lacrimal gland slices were incubated with carbachol in the presence and absence of different muscarinic antagonists. Protein secretion into the incubation medium was characterized with a Bio-Rad protein assay dye reagent in conjunction with Laemmli's method of SDS-PAGE. The medium protein profile was compared to that in tear samples.
RESULTS: Dose dependent increases in protein secretion were elicited by carbachol between 10(-7) and 10(-4) M. During the first 20 min period, a maximal increase of 64% above the basal level was seen at the highest concentration. With 10(-4) M carbachol, the response was transient because after 100 min it decreased to its basal level. The increases in protein secretion caused by 10(-4) M carbachol were completely suppressed in the presence of 10(-5) M atropine. On the other hand, the relatively selective M1 antagonist, pirenzepine, at concentrations from 10(-6) M to 10(-4) M, had no effect on either the basal levels or the stimulatory effects of carbachol. Similarly, the relatively selective M2 antagonist, gallamine, at concentrations from 10(-6) M to 10(-4) M, had no effect on either of these levels. In contrast, the relatively selective M3 antagonist, 4-DAMP, at concentrations from 10(-6) M to 10(-4) M, progressively suppressed the stimulated level of protein secretion elicited by 10(-4) M carbachol without affecting the basal level. The protein profiles found in the tears and in the incubation medium were similar to one another.
CONCLUSION: In vitro rabbit lacrimal gland protein secretion is comparable to that in vivo. Cholinergic-mediated control of rabbit lacrimal gland protein secretion occurs through stimulation of the M3 muscarinic receptor subtype.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9192172     DOI: 10.1076/ceyr.16.6.614.5077

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  8 in total

1.  Pharmacological cholinergic blockade stimulates inflammatory cytokine production and lymphocytic infiltration in the mouse lacrimal gland.

Authors:  John D Pitcher; Cintia S De Paiva; Flavia S A Pelegrino; Andrew J McClellan; Jagdeep K Raince; Solherny B Pangelinan; Ehsan Rahimy; William J Farley; Michael E Stern; De-Quan Li; Stephen C Pflugfelder
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-05-16       Impact factor: 4.799

2.  Myoepithelial Cells: Their Origin and Function in Lacrimal Gland Morphogenesis, Homeostasis, and Repair.

Authors:  Helen P Makarenkova; Darlene A Dartt
Journal:  Curr Mol Biol Rep       Date:  2015-07-10

Review 3.  TFOS DEWS II pain and sensation report.

Authors:  Carlos Belmonte; Jason J Nichols; Stephanie M Cox; James A Brock; Carolyn G Begley; David A Bereiter; Darlene A Dartt; Anat Galor; Pedram Hamrah; Jason J Ivanusic; Deborah S Jacobs; Nancy A McNamara; Mark I Rosenblatt; Fiona Stapleton; James S Wolffsohn
Journal:  Ocul Surf       Date:  2017-07-20       Impact factor: 5.033

4.  Male NOD mouse external lacrimal glands exhibit profound changes in the exocytotic pathway early in postnatal development.

Authors:  Silvia R da Costa; Kaijin Wu; Michelle Mac Veigh; Mike Pidgeon; Chuanqing Ding; Joel E Schechter; Sarah F Hamm-Alvarez
Journal:  Exp Eye Res       Date:  2005-07-11       Impact factor: 3.467

5.  Role of parasympathetic nerves and muscarinic receptors in allergy and asthma.

Authors:  Gregory D Scott; Allison D Fryer
Journal:  Chem Immunol Allergy       Date:  2012-06-26

Review 6.  Ocular Autonomic Nervous System: An Update from Anatomy to Physiological Functions.

Authors:  Feipeng Wu; Yin Zhao; Hong Zhang
Journal:  Vision (Basel)       Date:  2022-01-14

7.  In vivo antimuscarinic actions of the third generation antihistaminergic agent, desloratadine.

Authors:  G Howell; L West; C Jenkins; B Lineberry; D Yokum; R Rockhold
Journal:  BMC Pharmacol       Date:  2005-08-18

Review 8.  [Results of the Dry Eye Research Grant Award 2016].

Authors:  A Musayeva; A Gericke; F Jäger; F Paulsen; M Braun; B Fabry; R Braun; D Pauly; C Holtmann; G Geerling
Journal:  Ophthalmologe       Date:  2021-04       Impact factor: 1.174

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.